- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
WSJ: Investors are Wary of a New Round of the "Crypto Winter"
Aethir Releases 12-Month Future Roadmap to Accelerate Growth in Global Enterprise AI Computing Business
24-hour Spot Funding Inflow/Outflow List: ETH Net Outflow of $126 million, ZEC Net Outflow of $18.2 million
Bloomberg: Fed Never So Split on Long Rate Strategy
Key Transaction Data: US 10-Year Treasury Yield Rises to 4.086%
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App